1. PI3K/Akt/mTOR Apoptosis
  2. Akt PI3K Apoptosis
  3. Apoptin-derived peptide

Apoptin-derived peptide is an antitumor polypeptide with cytotoxicity. Apoptin-derived peptide promotes apoptosis and necrosis of gastric cancer (GC) cells by regulating PI3K/AKT/ARNT signaling. Apoptin-derived peptide inhibited the invasion and migration of cancer cells, and inhibited the expression and phosphorylation of the subunit p85 of PI3K, which further inhibited the PI3K/AKT pathway involved in the development of gastric cancer.

For research use only. We do not sell to patients.

Custom Peptide Synthesis

Apoptin-derived peptide Chemical Structure

Apoptin-derived peptide Chemical Structure

CAS No. : 2232156-31-7

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Akt Isoform Specific Products:

View All PI3K Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Apoptin-derived peptide is an antitumor polypeptide with cytotoxicity. Apoptin-derived peptide promotes apoptosis and necrosis of gastric cancer (GC) cells by regulating PI3K/AKT/ARNT signaling. Apoptin-derived peptide inhibited the invasion and migration of cancer cells, and inhibited the expression and phosphorylation of the subunit p85 of PI3K, which further inhibited the PI3K/AKT pathway involved in the development of gastric cancer[1].

In Vitro

Apoptin-derived peptide (40-100 μg/mL, 24 h) promotes ARNT down-regulation by inhibiting the PI3K/AKT signaling pathway to reverse CDDP resistance in SGC-7901/CDDP cells[1].
Apoptin-derived peptide (10-30 μg/mL, 24 h) inhibits the migration and invasion in SGC-7901, SGC-7901/CDDP and MGC-803 cells[1].
Apoptin-derived peptide (30-60 μg/mL, 24 h) increases the CDDP sensitivity of SGC-7901/CDDP cells[1].
Apoptin-derived peptide (10-20 μg/mL, 24 h) increases the G2/M phase population and induces apoptosis in SGC-7901 and SGC-7901/CDDP cells.[1].
Apoptin-derived peptide (10-70 μg/mL, 4-24 h) has an excellent inhibitory effect in SGC-7901 and SGC-7901/CDDP cells.

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: HEK293, SGC-7901, SGC-7901/CDDP
Concentration: 10 μg/mL, 20 μg/mL, 30 μg/mL, 40 μg/mL, 50 μg/mL, 60 μg/mL, 70 μg/mL
Incubation Time: 4 h, 6 h, 8 h, 12 h, 18 h, 24 h
Result: Produced large effects in both SGC-7901 and SGC-7901/CDDP cells at 60 μg/mL for 6 h and had no obvious effect on HEK293 cells.

Apoptosis Analysis[1]

Cell Line: SGC-7901, SGC-7901/CDDP
Concentration: 30 μg/mL, 60 μg/mL
Incubation Time: 24 h
Result: Induced SGC-7901 cell apoptosis in a concentration dependent manner.
Induced considerable apoptotic cell death in SGC-7901/CDDP cells in a strong time- and dose-dependent fashion.

Cell Cycle Analysis[1]

Cell Line: SGC-7901, SGC-7901/CDDP
Concentration: 10 μg/mL, 20 μg/mL
Incubation Time: 24 h
Result: Increase the G2/M phase population.

Cell Invasion Assay[1]

Cell Line: SGC-7901, SGC-7901/CDDP, MGC-803
Concentration: 10 μg/mL, 20 μg/mL, 30 μg/mL
Incubation Time: 48 h
Result: Significantly reduced the number of invasive cells.

Cell Migration Assay [1]

Cell Line: SGC-7901, SGC-7901/CDDP, MGC-803
Concentration: 10 μg/mL, 20 μg/mL, 30 μg/mL
Incubation Time: 48 h
Result: Effectively inhibited the migration ability of MGC-803, SGC-7901, and SGC-7901/CDDP cells in a dose-dependent manner.

Western Blot Analysis[1]

Cell Line: SGC-7901, SGC-7901/CDDP
Concentration: 40 μg/mL, 60 μg/mL, 80 μg/mL, 100 μg/mL
Incubation Time: 24 h
Result: Significantly down-regulated the phosphorylation of p85 (p-p85) and AKT (p-AKT) proteins at concentrations from 40 μg/mL to 100 μg/mL.
Down-regulated the expression of MDR1 and ARTN in Apoptin-derived peptide-treated SGC-7901/CDDP cells.
Notably decreased p85 and AKT activities.
Molecular Weight

5177.33

Formula

C223H417N89O50S

CAS No.
Sequence

Met-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys-Pro-Pro-Ser-Lys-Lys-Arg-Ile-Arg-Ile-Gly-Ile-Ala-Gly-Ile-Thr-Ile-Thr-Leu-Ser-Leu-Arg-Pro-Arg-Thr-Ala-Lys-Arg-Arg-Ile-Arg-Leu

Sequence Shortening

MGRKKRRQRRRKPPSKKRIRIGIAGITITLSLRPRTAKRRIRL

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Apoptin-derived peptide Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Apoptin-derived peptide
Cat. No.:
HY-P10090
Quantity:
MCE Japan Authorized Agent: